XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2020 $ 267,530 $ 8 $ 676,956 $ 614 $ (410,048)
Beginning balance (in shares) at Dec. 31, 2020   79,316,261      
Exercise of stock options 3,874   3,874    
Exercise of stock options (in shares)   415,386      
Stock-based compensation 8,800   8,800    
Unrealized loss on marketable securities (204)     (204)  
Net income (loss) (52,171)       (52,171)
Ending balance at Mar. 31, 2021 227,829 $ 8 689,630 410 (462,219)
Ending balance (in shares) at Mar. 31, 2021   79,731,647      
Beginning balance at Dec. 31, 2021 $ 300,724 $ 8 748,036 (943) (446,377)
Beginning balance (in shares) at Dec. 31, 2021 81,986,192 81,986,192      
Exercise of stock options $ 2,483   2,483    
Exercise of stock options (in shares)   234,117      
Vesting of restricted stock units   104,368      
Stock-based compensation 11,939   11,939    
Unrealized loss on marketable securities (2,992)     (2,992)  
Net income (loss) (44,617)       (44,617)
Ending balance at Mar. 31, 2022 $ 267,537 $ 8 $ 762,458 $ (3,935) $ (490,994)
Ending balance (in shares) at Mar. 31, 2022 81,986,192 82,324,677